The Effect of Amantadine on Corneal Endothelium in Subjects with Parkinson's Disease

Ophthalmology

Volumn 117, Issue 6, 2010, Pages 1214-1219

  Chang, Ki Cheol ^a,b,c   Jeong, Jin Ho ^a,b   Kim, Mee Kum ^a,b   Wee, Won Ryang ^a,b   Lee, Jin Hak ^a,b,d   Jeon, Beom Seok ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Chonbuk National University   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMANTADINE SULFATE;

ADULT; AGED; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA EPITHELIUM; CORNEA THICKNESS; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SLIT LAMP; TREATMENT DURATION;

ADULT; AGED; AMANTADINE; ANTIPARKINSON AGENTS; CELL COUNT; CORNEAL DISEASES; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 77952891870     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.10.039     Document Type: Article

References (18)

1. Pearlman J.T., Kadish A.H., and Ramseyer J.C. Vision loss associated with amantadine hydrochloride use [letter]. JAMA 237 (1977) 1200
2. Blanchard D.L. Amantadine caused corneal edema [letter]. Cornea 9 (1990) 181
3. Fraunfelder F.T., and Meyer S.M. Amantadine and corneal deposits. Am J Ophthalmol 110 (1990) 96-97
4. Nogaki H., and Morimatsu M. Superficial punctate keratitis and corneal abrasion due to amantadine hydrochloride [letter]. J Neurol 240 (1993) 388-389
5. Hughes B., Feiz V., Flynn S.B., and Brodsky M.C. Reversible amantadine-induced corneal edema in an adolescent. Cornea 23 (2004) 823-824
6. Kubo S., Iwatake A., Ebihara N., et al. Visual impairment in Parkinson's disease treated with amantadine: case report and review of the literature. Parkinsonism Relat Disord 14 (2008) 166-169
7. Jeng B.H., Galor A., Lee M.S., et al. Amantadine-associated corneal edema: potentially irreversible even after cessation of the medication. Ophthalmology 115 (2008) 1540-1544
8. Chang K.C., Kim M.K., Wee W.R., and Lee J.H. Corneal endothelial dysfunction associated with amantadine toxicity. Cornea 27 (2008) 1182-1185
9. Dubow J.S., Rezak M., and Berman A.A. Reversible corneal edema associated with amantadine use: an unrecognized problem [letter]. Mov Disord 23 (2008) 2096-2097
10. Hadjikoutis S., Morgan J.E., Wild J.M., and Smith P.E. Ocular complications of neurological therapy. Eur J Neurol 12 (2005) 499-507
11. Ray W.A., and O'Day D.M. Statistical analysis of multi-eye data in ophthalmic research. Invest Ophthalmol Vis Sci 26 (1985) 1186-1188
12. Fahn S., and Isgreen W.P. Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind crossover analyses. Neurology 25 (1975) 695-700
13. Verhagen Metman L., Del Potto P., van den Munckhof P., et al. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Neurology 50 (1998) 1323-1326
14. French D.D., and Margo C.E. Postmarketing surveillance of corneal edema, Fuchs dystrophy, and amantadine use in the Veterans Health Administration. Cornea 26 (2007) 1087-1089
15. Sheng H., and Bullimore M.A. Factors affecting corneal endothelial morphology. Cornea 26 (2007) 520-525
16. Mac Rae S.M., Matsuda M., Shellans S., and Rich L.F. The effects of hard and soft contact lenses on the corneal endothelium. Am J Ophthalmol 102 (1986) 50-57
17. Lee J.S., Park W.S., Lee S.H., et al. A comparative study of corneal endothelial changes induced by different durations of soft contact lens wear. Graefes Arch Clin Exp Ophthalmol 239 (2001) 1-4
18. Schultz R.O., Matsuda M., Yee R.W., et al. Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol 98 (1984) 401-410